Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19
STras-Cov-2
1 other identifier
observational
300
1 country
1
Brief Summary
Odor and taste disturbances have increased dramatically during this time of the COVID-19 pandemic. Currently, we have very little information on the demographic and clinical characteristics of the affected population, on the severity and course of the olfactory / taste loss. The main objective of this research is to analyze the epidemiological, demographic and clinical characteristics of patients suspected or already confirmed of infection with SARS-Cov2 presenting with anosmia and / or ageusia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 3, 2020
CompletedFirst Submitted
Initial submission to the registry
December 22, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2021
CompletedDecember 28, 2020
December 1, 2020
1 year
December 22, 2020
December 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective analysis of demographic and clinical characteristics of patients with suspected or already confirmed SARS-Cov2 infection with anosmia and / or ageusia
The files analysed retrospectily from February 01, 2020 to June 03, 2020 will be examined]
Eligibility Criteria
Adult patient having had a loss of smell and / or taste that occurred during the period of the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19
You may qualify if:
- Major subject (≥18 years old)
- Subject having had a loss of smell and / or taste that occurred during the period of the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19
- Subject with suspected or confirmed Covid-19 infection
- Subject taken care of by the ENT service
- Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.
You may not qualify if:
- Subject having expressed opposition to participating in the study
- Subject under guardianship or guardianship
- Subject under safeguard of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Strasbourg University Hospitals - Otorhino-Laryngology Department
Strasbourg, Starsbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2020
First Posted
December 23, 2020
Study Start
April 3, 2020
Primary Completion
April 3, 2021
Study Completion
April 3, 2021
Last Updated
December 28, 2020
Record last verified: 2020-12